Boston Scientific (BSX) Non Operating Income (2009 - 2024)

Boston Scientific has disclosed Non Operating Income across 16 years of filings, most recently posting -$65.0 million for Q3 2024.

• In Q3 2024, Non Operating Income rose 21.69% year-over-year to -$65.0 million; the TTM figure through Sep 2024 stood at -$311.0 million (down 9.12% YoY), while the FY2023 annual figure was -$358.0 million, up 29.53% from the prior year.
• Non Operating Income came in at -$65.0 million for Q3 2024 at Boston Scientific, up from -$100.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $257.0 million in Q4 2020 to a low of -$310.0 million in Q1 2022.
• Average Non Operating Income over 5 years is -$64.3 million, with a median of -$79.0 million recorded in 2023.
• Year-over-year, Non Operating Income surged 531.82% in 2021 and slumped 1216.67% in 2023.
• Over 5 years, Non Operating Income stood at $257.0 million in 2020, then slumped by 123.74% to -$61.0 million in 2021, then surged by 90.16% to -$6.0 million in 2022, then tumbled by 1216.67% to -$79.0 million in 2023, then gained by 17.72% to -$65.0 million in 2024.
• Per Business Quant data, the three most recent Non Operating Income figures were -$65.0 million in Q3 2024, -$100.0 million in Q2 2024, and -$67.0 million in Q1 2024.